C Paul

Suggest Changes
Learn More
BACKGROUND Apremilast, an oral phosphodiesterase 4 inhibitor, regulates immune responses associated with psoriasis. OBJECTIVES ESTEEM 2 evaluated the efficacy and safety of apremilast 30 mg twice(More)
BACKGROUND Available psoriasis surveys offer valuable information about psoriasis and psoriatic arthritis (PsA), but are limited by methodology or enrollment requirements. OBJECTIVE To further the(More)